3,492
Views
8
CrossRef citations to date
0
Altmetric
Review

How far have biological therapies come in regenerative sports medicine?

&
Pages 785-793 | Received 21 Feb 2018, Accepted 20 Jun 2018, Published online: 09 Jul 2018

References

  • [cited 2018 Feb 2]. Available from: http://www.who.int/dietphysicalactivity/publications/9789241599979/en/
  • O’Donovan G, Lee IM, Hamer M, et al. Association of “weekend warrior” and other leisure time physical activity patterns with risks for all-cause, cardiovascular disease, and cancer mortality. JAMA Intern Med. 2017;177(3):335–342.
  • Fairman CM, Zourdos MC, Helms ER, et al. Rationale to improve resistance training prescription in exercise oncology. Sports Med. 2017;47(8):1457–1465.
  • Hilfiker R, Meichtry A, Eicher M, et al. Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis. Br J Sports Med. 2018 May;52(10):651–658.
  • Schenkman M, Moore CG, Kohrt WM, et al. Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol. 2018;75(2):219–226.
  • Vidoni ED, Perales J, Alshehri M, et al. Aerobic exercise sustains performance of instrumental activities of daily living in early-stage alzheimer disease. J Geriatr Phys Ther. 2017 Dec 28; doi:10.1519/JPT.0000000000000172.
  • Sherrington C, Michaleff ZA, Fairhall N, et al. Exercise to prevent falls in older adults: an updated systematic review and meta-analysis. Br J Sports Med. 2017;51(24):1750–1758.
  • Best TM, Caplan A, Coleman M, et al. Not missing the future: a call to action for investigating the role of regenerative medicine therapies in pediatric/adolescent sports injuries. Curr Sports Med Rep. 2017;16(3):202–210.
  • Schwebel DC, Brezausek CM. Child development and pediatric sport and recreational injuries by age. J Athl Train. 2014;49(6):780–785.
  • Burchard R, Stolpp A, Kratz T, et al. School sport-associated injuries in adolescents: A single center experience. Technol Health Care. 2017;25(6):1053–1059.
  • Welton KL, Kraeutler MJ, Pierpoint LA, et al. Injury recurrence among high school athletes in the united states: a decade of patterns and trends, 2005-2006 through 2015-2016. Orthop J Sports Med. 2018 Jan 2;6(1):2325967117745788.
  • Paterno MV, Huang B, Thomas S, et al. Clinical factors that predict a second acl injury after acl reconstruction and return to sport: preliminary development of a clinical decision algorithm. Orthop J Sports Med. 2017;5(12):2325967117745279.
  • Hamrin Senorski E, Seil R, Svantesson E, et al. “I never made it to the pros…” return to sport and becoming an elite athlete after pediatric and adolescent anterior cruciate ligament injury-current evidence and future directions. Knee Surg Sports TraumatolArthrosc. 2018 Apr;26(4):1011–1018.
  • Smith MV, Nepple JJ, Wright RW, et al. Knee osteoarthritis is associated with previous meniscus and anterior cruciate ligament surgery among elite college american football athletes. Sports Health. 2017;9(3):247–251.
  • Carbone A, Rodeo S. Review of current understanding of post-traumatic osteoarthritis resulting from sports injuries. J Orthop Res. 2017;35(3):397–405.
  • Ciccotti MC, Secrist E, Tjoumakaris F, et al. anatomic anterior cruciate ligament reconstruction via independent tunnel drilling: a systematic review of randomized controlled trials comparing patellar tendon and hamstring autografts. Arthroscopy. 2017;33(5):1062–1071.
  • Khan T, Alvand A, Prieto-Alhambra D, et al. ACL and meniscal injuries increase the risk of primary total knee replacement for osteoarthritis: a matched case-control study using the clinical practice research datalink (CPRD). Br J Sports Med. 2018 Jan 13;bjsports-2017–097762. doi:10.1136/bjsports-2017-097762.
  • Silvers-Granelli HJ, Bizzini M, Arundale A, et al. Does the FIFA 11+ injury prevention program reduce the incidence of ACL injury in male soccer players? Clin Orthop Relat Res. 2017;475(10):2447–2455.
  • Bittencourt NF, Meeuwisse WH, Mendonça LD, et al. Complex systems approach for sports injuries: moving from risk factor identification to injury pattern recognition-narrative review and new concept. Br J Sports Med. 2016 Jul 21;bjsports-2015–095850.
  • Flanigan DC, Harris JD, Trinh TQ, et al. Prevalence of chondral defects in athletes’ knees: a systematic review. Med Sci Sports Exerc. 2010;42(10):1795–1801.
  • Petrillo S, Papalia R, Maffulli N, et al. Osteoarthritis of the hip and knee in former male professional soccer players. Br Med Bull. 2018 Jan;29: doi:10.1093/bmb/ldy001
  • Vigdorchik JM, Nepple JJ, Eftekhary N, et al. What is the association of elite sporting activities with the development of hip osteoarthritis? Am J Sports Med. 2017;45(4):961–964.
  • Morton S, Williams S, Valle X, et al. Patellar tendinopathy and potential risk factors: an international database of cases and controls. Clin J Sport Med. 2017;27(5):468–474.
  • Jacobsson J, Timpka T, Kowalski J, et al. Prevalence of musculoskeletal injuries in swedish elite track and field athletes. Am J Sports Med. 2012;40(1):163–169.
  • Zouzias IC, Hendra J, Stodelle J, et al. Golf injuries: epidemiology, pathophysiology, and treatment. J Am AcadOrthop Surg. 2018 Jan 11; Epub ahead of print. doi:10.5435/JAAOS-D-15-00433
  • Lin DJ, Wong TT, Kazam JK. Shoulder injuries in the overhead-throwing athlete: epidemiology, mechanisms of injury, and imaging findings. Radiology. 2018;286(2):370–387.
  • Andia I, Maffulli N. Biological therapies in regenerative sports medicine. Sports Med. 2017;47(5):807–828.
  • Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013;9(12):721–730.
  • McIntyre JA, Jones IA, Danilkovich A, et al. The placenta: applications in orthopaedic sports medicine. Am J Sports Med. 2018;46(1):234–247.
  • Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331(14):889–895.
  • Cherian JJ, Parvizi J, Bramlet D, et al. Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee. Osteoarthritis Cartilage. 2015;23(12):2109–2118.
  • Elmallah RK, Cherian JJ, Jauregui JJ, et al. Genetically modified chondrocytes expressing TGF-β1: a revolutionary treatment for articular cartilage damage? Expert Opin Biol Ther. 2015;15(3):455–464.
  • Wang A, Breidahl W, Mackie KE, et al. Autologous tenocyte injection for the treatment of severe, chronic resistant lateral epicondylitis: a pilot study. Am J Sports Med. 2013;41(12):2925–2932.
  • Wang A, Mackie K, Breidahl W, et al. Evidence for the durability of autologous tenocyte injection for treatment of chronic resistant lateral epicondylitis: mean 4.5-year clinical follow-up. Am J Sports Med. 2015;43(7):1775–1783.
  • Somoza RA, Welter JF, Correa D, et al. Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. Tissue Eng Part B Rev. 2014;20(6):596–608.
  • Lee JI, Balolong E, Han Y, et al. Stem cells for cartilage repair: what exactly were used for treatment, cultured adipose-derived stem cells or the unexpanded stromal vascular fraction? Osteoarthritis Cartilage. 2016;24(7):1302–1303.
  • Koh YG, Kwon OR, Kim YS, et al. Adipose-derived mesenchymal stem cells withmicrofracture versus microfracture alone: 2-year follow-up of a prospective randomized trial. Arthroscopy. 2016;32(1):97–109.
  • Buda R, Castagnini F, Cavallo M, et al. “One-step” bone marrow-derived cells transplantation and joint debridement for osteochondral lesions of the talus in ankle osteoarthritis: clinical and radiological outcomes at 36 months. Arch Orthop Trauma Surg. 2016;136:107–116.
  • Chu CR, Fortier LA, Williams A, et al. Minimally manipulated bone marrow concentrate compared with microfracture treatment of full-thickness chondral defects: a one-year study in an equine model. J Bone Joint Surg Am. 2018;100(2):138–146.
  • Kim YS, Kwon OR, Choi YJ, et al. Comparative matched-pair analysis of the injection versus implantation of mesenchymal stem cells for knee osteoarthritis. Am J Sports Med. 2015;43(11):2738–2746.
  • Choudhery MS, Badowski M, Muise A, et al. Subcutaneous adipose tissue-derived stem cell utility is independent of anatomical harvest site. Biores Open Access. 2015;4(1):131–145.
  • Aronowitz JA, Lockhart RA, Hakakian CS. Mechanical versus enzymatic isolation of stromal vascular fraction cells from adipose tissue. Springerplus. 2015 Nov;23(4):713.
  • Kondo S, Muneta T, Nakagawa Y, et al. Transplantation of autologous synovial mesenchymal stem cells promotes meniscus regeneration in aged primates. J Orthop Res. 2017;35(6):1274–1282.
  • Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19(6):902–907.
  • Sekiya I, Muneta T, Horie M, et al. Arthroscopic transplantation of synovial stem cells improves clinical outcomes in knees with cartilage defects. Clin Orthop Relat Res. 2015;473(7):2316–2326.
  • Schäfer R, Spohn G, Baer PC. mesenchymal stem/stromal cells in regenerative medicine: can preconditioning strategies improve therapeutic efficacy? Transfus Med Hemother. 2016;43(4):256–267.
  • Xu Z, Luo J, Huang X, et al. Efficacy of Platelet-Rich Plasma in Pain and Self-Report Function in Knee Osteoarthritis: a Best-Evidence Synthesis. Am J Phys Med Rehabil. 2017;96(11):793–800.
  • Huang H, Xu H, Zhao J, et al. Approach for meniscal regeneration using kartogenin-treated autologous tendon graft. Am J Sports Med. 2017;45(14):3289–3297.
  • Johnson K, Zhu S, Tremblay MS, et al. A stem cell-based approach to cartilage repair. Science. 2012;336(6082):717–721.
  • Embree MC, Chen M, Pylawka S, et al. Exploiting endogenous fibrocartilage stem cells to regenerate cartilage and repair joint injury. Nat Commun. 2016 Oct 10;7:13073.
  • Jeon OH, Kim C, Laberge RM, et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med. 2017;23(6):775–781.
  • Dohan Ehrenfest DM, Andia I, Zumstein MA, et al. Classification of platelet concentrates (platelet-rich plasma-prp, platelet-rich fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014;4(1):3–9.
  • Chahla J, Cinque ME, Piuzzi NS, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am. 2017;99(20):1769–1779.
  • Murray IR, Geeslin AG, Goudie EB, et al. Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am. 2017;99(10):809–819.
  • Smith PA. Intraarticular autologous conditioned plasma provide safe and efficacious treatment for knee osteoarthritis. Am J Sports Med. 2016;44(4):884–891.
  • Zhang Y, Wei X, Browning S, et al. designed variants of alpha-2-macroglobulin (A2M) attenuate cartilage degeneration in a rat model of osteoarthritis induced by anterior cruciate ligament transection.Arthritis. Res Ther. 2017 Jul 25;19(1):175.
  • Shimberg M. The use of amniotic-fluid concentrate in orthopaedic conditions. J Bone Jt Surg. 1938;20(1):167–177.
  • Gellhorn AC, Han A. The use of dehydrated human amnion/chorion membrane allograft injection for the treatment of tendinopathy or arthritis: a case series involving 40 patients. PM R. 2017;9(12):1236–1243.
  • Hanselman AE, Tidwell JE, Santrock RD. Cryopreserved human amniotic membrane injection for plantar fasciitis: a randomized, controlled, double-blind pilot study. Foot Ankle Int. 2015;36(2):151–158.
  • Pas HIMFL, Moen MH, Haisma HJ, et al. No evidence for the use of stem cell therapy for tendon disorders: a systematic review. Br J Sports Med. 2017;51(13):996–1002.
  • Pas HI, Winters M, Haisma HJ, et al. Stem cell injections in knee osteoarthritis: a systematic review of the literature. Br J Sports Med. 2017;51(15):1125–1133.
  • Zayni R, Thaunat M, Fayard JM, et al. Platelet-rich plasma as a treatment for chronic patellar tendinopathy: comparison of a single versus two consecutive injections. Muscles Ligaments Tendons J. 2015;5(2):92–98.
  • Pascual-Garrido C, Rolón A, Makino A. Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: a 5-year-followup. Stem Cells Int. 2012;2012:953510.
  • Dupley L, Charalambous CP. Platelet-rich plasma injections as a treatment for refractory patellar tendinosis: a meta-analysis of randomised trials. Knee Surg Relat Res. 2017;29(3):165–171.
  • Usuelli FG, Grassi M, Maccario C, et al. Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious treatment for achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up. Knee Surg Sports TraumatolArthrosc. 2017 Mar 1; doi:10.1007/s00167-017-4479-9.
  • De Vos RJ, Weir A, Van Schie HT, et al. Platelet-rich plasma injection for chronic achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2):144–149.
  • Boesen AP, Hansen R, Boesen MI, et al. Effect of high-volume injection, platelet-rich plasma, and sham treatment in chronic midportion achilles tendinopathy: a randomized double-blinded prospective study. Am J Sports Med. 2017;45(9):2034–2043.
  • Yang WY, Han YH, Cao XW, et al. Platelet-rich plasma as a treatment for plantar fasciitis: A meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017;96(44):e8475.
  • Singh A, Gangwar DS, Singh SB. marrow injection: A novel treatment for tennis elbow. J Nat Sci Biol Med. 2014;5(2):389–391.
  • Lee SY, Kim W, Lim C, et al. Treatment of lateral epicondylosis by using allogeneic adipose-derived mesenchymal stem cells: a pilot study. Stem Cells. 2015;33(10):2995–3005.
  • Mi B, Liu G, Zhou W, et al. Platelet rich plasma versus steroid on lateral epicondylitis: meta-analysis of randomized clinical trials. Phys Sports Med. 2017;45(2):97–104.
  • Tsikopoulos K, Tsikopoulos I, Simeonidis E, et al. The clinical impact of platelet-rich plasma on tendinopathy compared to placebo or dry needling injections: a meta-analysis. Phys Ther Sport. 2016;17:87–94.
  • Montalvan B, Le Goux P, Klouche S, et al. Inefficacy of ultrasound-guided local injections of autologous conditioned plasma for recent epicondylitis: results of a double-blind placebo-controlled randomized clinical trial with one-year follow-up. Rheumatology (Oxford). 2016;55(2):279–285.
  • Centeno CJ, Al-Sayegh H, Bashir J, et al. A prospective multi-site registry study of a specific protocol of autologous bone marrow concentrate for the treatment of shoulder rotator cuff tears and osteoarthritis. J Pain Res. 2015;8:269–276.
  • Fu CJ, Sun JB, Bi ZG, et al. Evaluation of platelet-rich plasma and fibrin matrix to assist in healing and repair of rotator cuff injuries: a systematic review and meta-analysis. Clin Rehabil. 2017;31(2):158–172.
  • Ebert JR, Wang A, Smith A, et al. A midterm evaluation of postoperative platelet-rich plasma injections on arthroscopic supraspinatus repair: a randomized controlled trial. Am J Sports Med. 2017;45(13):2965–2974.
  • Fitzpatrick J, Bulsara M, Zheng MH. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2017;45(1):226–233.
  • Chen CPC, Cheng CH, Hsu CC, et al. The influence of platelet rich plasma on synovial fluid volumes, protein concentrations, and severity of pain in patients with knee osteoarthritis. Exp Gerontol. 2017;93:68–72.
  • Miller LE, Parrish WR, Roides B, et al. Efficacy of platelet-rich plasma injections for symptomatic tendinopathy: systematic review and meta-analysis of randomised injection-controlled trials. BMJ Open Sport Exerc Med. 2017 Nov 6;3(1):e000237.
  • Wakitani S, Okabe T, Horibe S, et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med. 2011;5(2):146–150.
  • Centeno CJ, Al-Sayegh H, Freeman MD, et al. A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions. Int Orthop. 2016;40(8):1755–1765.
  • Peeters CM, Leijs MJ, Reijman M, et al. Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. Osteoarthritis Cartilage. 2013;21(10):1465–1473.
  • Pak J, Chang JJ, Lee JH, et al. Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints. BMC Musculoskelet Disord. 2013 Dec;1(14):337.
  • Gobbi A, Karnatzikos G, Scotti C, et al. One-step cartilage repair with bone marrow aspirate concentrated cells and collagen matrix in full-thickness knee cartilage lesions: results at 2-year follow-up. Cartilage. 2011;2(3):286–299.
  • Buda R, Vannini F, Castagnini F, et al. Regenerative treatment in osteochondral lesions of the talus: autologous chondrocyte implantation versus one-step bone marrow derived cells transplantation. Int Orthop. 2015;39(5):893–900.
  • Akgun I, Unlu MC, Erdal OA, et al. Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study. Arch Orthop Trauma Surg. 2015 Feb;135(2):251–263.
  • Usuelli FG, D’Ambrosi R, Maccario C, et al. Adipose-derived stem cells in orthopaedic pathologies. Br Med Bull. 2017;124(1):31–54.
  • Guney A, Akar M, Karaman I, et al. Clinical outcomes of platelet rich plasma (PRP) as an adjunct to microfracture surgery in osteochondral lesions of the talus. Knee Surg Sports TraumatolArthrosc. 2015;23(8):2384–2389.
  • Mei-Dan O, Carmont MR, Laver L, et al. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med. 2012;40(3):534–541.
  • Elghawy AA, Sesin C, Rosselli M. Osteochondral defects of the talus with a focus on platelet-rich plasma as a potential treatment option: a review. BMJ Open Sport Exerc Med. 2018 Feb 1;4(1):e000318.
  • Shapiro SA, Kazmerchak SE, Heckman MG, et al. Single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med. 2017;45(1):82–90.
  • Altman RD, Devji T, Bhandari M, et al. Clinical benefit of intra-articular saline as a comparator in clinical trials of knee osteoarthritis treatments: a systematic review and meta-analysis of randomized trials. Semin Arthritis Rheum. 2016;46(2):151–159.
  • Shen L, Yuan T, Chen S, et al. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017 Jan 23;12(1):16.
  • Dai WL, Zhou AG, Zhang H, et al. Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Arthroscopy. 2017;33(3):659–670.
  • Munsie M, Hyun I. A question of ethics: selling autologous stem cell therapies flaunts professional standards. Stem Cell Res. 2014;13(3Pt B):647–653.
  • Rachul C, Rasko JEJ, Caulfield T. Implicit hype? representations of platelet rich plasma in the news media. PLoS One. 2017 Aug 9;12(8):e0182496.
  • McNamee MJ, Coveney CM, Faulkner A, et al. Evidence based sports medicine, and the use of platelet rich plasma in the english premier league. Health Care Anal. 2017 Jul;29: doi:10.1007/s10728-017-0345-7
  • LeighTurner P. Knoepfler. selling stem cells in the USA: assessing the direct-to-consumer industry. Cell Stem Cell. 2016;19(2):154–157.
  • Matthews KR, Cuchiara MLUS. National football league athletes seeking unproven stem cell treatments. Stem Cells Dev. 2014 Dec;23(Suppl 1):60–64.